Skip to main content

. 1953 Mar;12(1):20–24. doi: 10.1136/ard.12.1.20

Clinical Studies of Phenylbutazone (Butazolidin) and Butapyrin (Irgapyrin) in Rheumatoid Arthritis, Rheumatoid Spondylitis, and Gout ^{^*}

E G Kidd ^1,^†, K C Boyce ^1,^†, R H Freyberg ¹

PMCID: PMC1030429 PMID: 13031444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BERSHOF E., OXMAN A. C. Agranulocytosis following use of phenylbutazone (butazolidin). J Am Med Assoc. 1953 Feb 14;151(7):557–558. doi: 10.1001/jama.1953.02940070023007b. [DOI] [PubMed] [Google Scholar]
CURRIE J. P. Treatment of rheumatoid arthritis with butazolidine . Lancet. 1952 Jul 5;2(6723):15–16. doi: 10.1016/s0140-6736(52)91642-5. [DOI] [PubMed] [Google Scholar]
FABRE J., MACH R. S. L'action de l'Irgapyrine sur les métabolismes du sel et de l'eau et sur les fonctions renales. Schweiz Med Wochenschr. 1951 May 19;81(20):473–477. [PubMed] [Google Scholar]
FISCHER H. Uber Irgapyrin, ein neues Mittel zur parenteralen Pyrazoltherapie der rheumatischen Polyarthritis. Dtsch Med Wochenschr. 1951 Jan 12;76(2):50–54. doi: 10.1055/s-0028-1116582. [DOI] [PubMed] [Google Scholar]
JAQUES R., DOMENJOZ R. Histaminantagonistische Wirkung bei Pyrazolen und Antihistaminen. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1950;212(1-2):124–125. [PubMed] [Google Scholar]
KUZELL W. C. Diseases of bones and joints. Annu Rev Med. 1951;2:367–434. doi: 10.1146/annurev.me.02.020151.002055. [DOI] [PubMed] [Google Scholar]
KUZELL W. C., SCHAFFARZICK R. W., BROWN B., MANKLE E. A. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout. J Am Med Assoc. 1952 Jun 21;149(8):729–734. doi: 10.1001/jama.1952.02930250011004. [DOI] [PubMed] [Google Scholar]
SELIGER H. Irgapyrin bei rheumatichen Erkrankungen. Arztl Wochensch. 1951 Jan 26;6(4):89–90. [PubMed] [Google Scholar]
STEINBROCKER O., BERKOWITZ S., EHRLICH M., ELKIND M., CARP S. Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders. J Am Med Assoc. 1952 Nov 15;150(11):1087–1091. doi: 10.1001/jama.1952.03680110027008. [DOI] [PubMed] [Google Scholar]
STEPHENS C. A. L., Jr, YEOMAN E. E., HOLBROOK W. P., HILL D. F., GOODIN W. L. Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis. J Am Med Assoc. 1952 Nov 15;150(11):1084–1086. doi: 10.1001/jama.1952.03680110024007. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES